BTC Health Ltd Signs Exclusive Distribution Agreement with Micrel Medical Devices

BTC Health Limited (ASX: BTC) has announced a significant development through its subsidiary, BioImpact Pty Ltd. BioImpact has secured exclusive sales and distribution rights for the Rhythm™ Evolution infusion pumps in the Australian and New Zealand markets. The Rhythm™ Evolution pumps are a top-tier line of electronic infusion pumps and administration sets designed for both hospital and homecare settings. These pumps, classified as Class IIb reusable medical devices, support the continuous and bolus administration of various therapeutic medicines, ranging from post-operative pain management and obstetrics to antibiotic therapy, oncology, and immunoglobulin infusions.

The launch of this product range is contingent upon receiving marketing approval from regulatory bodies, specifically the Therapeutic Goods Administration in Australia and Medsafe in New Zealand. Anticipated for FY24, this introduction aligns with BTC Health's strategic goal of phasing out the ambIT® product range in Australia and New Zealand by mid-2024. This exclusive distribution agreement marks a significant step forward for BTC Health and its commitment to delivering high-quality medical solutions to the healthcare industry.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com